1. Home
  2. SPPL vs CDT Comparison

SPPL vs CDT Comparison

Compare SPPL & CDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SPPL
  • CDT
  • Stock Information
  • Founded
  • SPPL 2016
  • CDT 2019
  • Country
  • SPPL Singapore
  • CDT United States
  • Employees
  • SPPL N/A
  • CDT N/A
  • Industry
  • SPPL
  • CDT Biotechnology: Pharmaceutical Preparations
  • Sector
  • SPPL
  • CDT Health Care
  • Exchange
  • SPPL Nasdaq
  • CDT Nasdaq
  • Market Cap
  • SPPL 11.3M
  • CDT 11.1M
  • IPO Year
  • SPPL 2023
  • CDT N/A
  • Fundamental
  • Price
  • SPPL $0.58
  • CDT $1.15
  • Analyst Decision
  • SPPL
  • CDT
  • Analyst Count
  • SPPL 0
  • CDT 0
  • Target Price
  • SPPL N/A
  • CDT N/A
  • AVG Volume (30 Days)
  • SPPL 149.3K
  • CDT 8.8M
  • Earning Date
  • SPPL 12-31-2024
  • CDT 03-04-2025
  • Dividend Yield
  • SPPL N/A
  • CDT N/A
  • EPS Growth
  • SPPL N/A
  • CDT N/A
  • EPS
  • SPPL N/A
  • CDT N/A
  • Revenue
  • SPPL $3,470,469.00
  • CDT N/A
  • Revenue This Year
  • SPPL N/A
  • CDT N/A
  • Revenue Next Year
  • SPPL N/A
  • CDT N/A
  • P/E Ratio
  • SPPL N/A
  • CDT N/A
  • Revenue Growth
  • SPPL N/A
  • CDT N/A
  • 52 Week Low
  • SPPL $0.25
  • CDT $1.13
  • 52 Week High
  • SPPL $5.89
  • CDT $392.00
  • Technical
  • Relative Strength Index (RSI)
  • SPPL 36.67
  • CDT 31.53
  • Support Level
  • SPPL $0.57
  • CDT $1.60
  • Resistance Level
  • SPPL $0.74
  • CDT $3.70
  • Average True Range (ATR)
  • SPPL 0.07
  • CDT 0.44
  • MACD
  • SPPL 0.00
  • CDT 0.09
  • Stochastic Oscillator
  • SPPL 12.70
  • CDT 0.78

About SPPL SIMPPLE LTD.

Simpple Ltd delivers an ecosystem solution that combines Internet-of-Things devices, robotic solutions and an integrated software system operating in unison to position buildings to be future-ready. The company operates through two primary segments: the sale, warranty, and maintenance of autonomous robotic cleaning equipment (Robots), and the sale of facilities management software. The majority of its revenue is generated from the Robots segment.

About CDT Conduit Pharmaceuticals Inc.

Conduit Pharmaceuticals Inc is a clinical-stage specialty biopharmaceutical company that was formed to facilitate the development and commercialization of clinical assets that have not been or are not being, prioritized by leading biopharmaceutical companies in order to develop pharmaceutical products that meet the unmet medical needs of patients. The Company's current development pipeline includes a glucokinase activator, which is Phase II ready in autoimmune diseases including uveitis, Hashimoto's Thyroiditis, preterm labor and renal transplant rejection. The Company's development pipeline also includes a potent, irreversible inhibitor of human Myeloperoxidase (MPO) that has the potential to treat idiopathic male infertility.

Share on Social Networks: